Zenas Biopharma's Purchased 60,000: Insider Buy Deep Dive
A biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
Wealth accumulation strategies can differ between stocks and real estate. Explore the pros and cons of each to make the best choice for your finances.
23,705 articlesA biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
PepsiCo stock faces a potential move toward $180 as analysts cite World Cup-driven demand, cost cuts, and internation...
As market volatility persists in June 2026, retirees with shares pulling increasingly rely on covered calls on IWM to...
As of mid-2026, JEPI remains a focal point for investors seeking steady monthly income, but the dividend safety check...
Palo Alto Networks leads a broad cybersecurity rally as UBS projects a multibillion-dollar market by 2026, sparking c...
A revival in small-cap stocks is taking shape as three key forces converge. AI-driven demand, a steadier macro backdr...
Bitcoin remains perched above the $62,000 level as traders rotate back into risk assets. Altcoins like HYPE and ADA l...
Analysts warn that the stock market’s double bubble could burst if corporate earnings fail to keep pace with lofty pr...
A new Morgan Stanley note argues Rocket Lab’s shift into satellite data and services could unlock substantial upside,...
A veteran Jefferies strategist outlines a split AI spend cycle: upfront hardware capex drives early gains, while long...
Hynix’s move onto the Nasdaq marks a watershed moment for foreign listings in the U.S. tech space. This article break...
Eli Lilly stock could advance in the second half of 2026 as Foundayo gains traction and the GLP-1 franchise shines, b...